Skip to main content Deutsch

Sortiert nach PI

Sorry, this content is only available in German!

Publikationen - sortiert nach Principle Investigator

Medical NeuroScience Cluster Publications by Freissmuth, Michael

Last year | Last five years | All

2021 Original Articles

  • Muratspahić E, Tomašević N, Nasrollahi-Shirazi S, Gattringer J, Emser FS, Freissmuth M, Gruber CW (2021) Plant-Derived Cyclotides Modulate κ-Opioid Receptor Signaling. J Nat Prod, 84(8): 2238-2248
  • Bhat S, Guthrie DA, Kasture A, El-Kasaby A, Cao J, Bonifazi A, Ku T, Giancola JB, Hummel T, Freissmuth M, Newman AH (2021) Tropane-based ibogaine analog rescues folding-deficient serotonin and dopamine transporters. ACS, 4: 503-516
  • 191. Ng J, Barral S, De La Fuente Barrigon C, Lignani G, Erdem FA, Wallings R, Privolizzi R, Rossignoli G, Alrashidi H, Heasman S, Meyer E, Ngoh A, Pope S, Karda R, Perocheau D, Baruteau J, Suff N, Antinao Diaz J, Schorge S, Vowles J, Marshall LR, Cowley SA, Sucic S, Freissmuth M, Counsell J, Wade-Martins R, Heales SJR, Rahim AA, Bencze M, Waddington SN, Kurian MA (2021) Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism. Sci Transl Med, 13(594): eaaw1564
  • Esendir E, Burtscher V, Coleman JA, Zhu R, Gouaux E, Freissmuth M, Sandtner W (2021) Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding J Biol Chem, 297(1): 00863
  • Schicker K, Bhat S, Farr C, Burtscher V, Horner A, Freissmuth M, Sandtner W (2021) Descriptors of Secondary Active Transporter Function and How They Relate to Partial Reactions in the Transport Cycle Membran, 11 (3): 178

2020 Original Articles

  • Burtscher V, Hotka M, Freissmuth M, Sandtner W (2020) An electrophysiological approach to measure changes in the membrane surface potential in real time Biophys. J, 118(4): 813-825
  • Nasrollahi-Shirazi S, Szöllösi D, Yang Q, Muratspahic E, El-Kasaby A, Sucic S, Stockner T, Nanoff C, Freissmuth M (2020) Functional impact of the G279S substitution in the adenosine A1-receptor (A1R-G279S), a mutation associated with Parkinson's disease Mol Pharmacol, 98: 250–266